Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FC4NU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,349
Award facts
- Contract value 100% obligated
- $30,348.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) under a firm fixed price contract valued at $30,348.52. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order supports the Defense Health Agency and other government healthcare customers by providing Jardiance, a diabetes management medication, consistent with AmerisourceBergen's established portfolio of pharmaceutical deliveries across multiple therapeutic domains.
This delivery order is executed under AmerisourceBergen's existing prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract vehicle establishes AmerisourceBergen as a pharmaceutical prime vendor for global military healthcare support, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic categories. The company's competitive positioning within the federal medical supply market is demonstrated through its consistent receipt of non-set-aside delivery orders, which showcase its capability to meet federal procurement standards through open competition and deliver specialized pharmaceutical commodities to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FC4NU?
SPE2DB25FC4NU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FC4NU worth?
The government has obligated $30,349 on SPE2DB25FC4NU.
Is contract SPE2DB25FC4NU an order under another contract?
Yes. SPE2DB25FC4NU is a delivery order under SPE2DB20D7066, an indefinite delivery contract.
Was contract SPE2DB25FC4NU competed?
The extent of competition for SPE2DB25FC4NU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award